Virgil Thompson

Virgil Thompson

Nessuna posizione attualmente
86 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Virgil D.
Thompson
served as President, CEO, and Director at various pharmaceutical companies including Splash Pharmaceuticals, Cytel Corp., Chimeric Therapies, Cibus Pharmaceuticals, Questcor Pharmaceuticals, and Savient Pharmaceuticals.
He also served as Chairman at Questcor Pharmaceuticals and Spinnaker Biosciences, and as an Independent Director at Soligenix, Aradigm Corp., GenZ Corp., and Processa Pharmaceuticals.
Thompson was also a Director at Mallinckrodt Plc and Promet Therapeutics LLC.
Prior to his work in the pharmaceutical industry, Thompson served as President of Syntex Laboratories, Inc. and as COO of Syntex Corp.
Thompson received his undergraduate degree from the University of Kansas and his graduate degree from George Washington University Law School.

Precedenti posizioni note di Virgil Thompson

SocietàPosizioneFine
Amministratore Delegato 01/07/2015
PROCESSA PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 09/11/2023
ARADIGM CORPORATION Presidente 01/07/2017
Direttore/Membro del Consiglio 01/01/2017
QUESTCOR PHARMACEUTICALS INC Presidente 14/08/2014
Vedi nel dettaglio l'esperienza di Virgil Thompson

Formazione di Virgil Thompson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

64

Relazioni di 1° grado

17

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Syntex Laboratories, Inc.

Cytel Corp.

Chimeric Therapies, Inc.

Cibus Pharmaceuticals, Inc.

Health Services

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Virgil Thompson